[Clinical studies on the biliary excretion of mezlocillin, especially in cases with liver dysfunction].
To investigate efficacy of mezlocillin (MZPC) in the treatment of biliary tract infection, the time course concentrations of MZPC in the bile of patients with, in particular, liver dysfunction were measured. MZPC concentrations in the bile decreased with the increase in the severity of liver dysfunction. However, the bile concentration was maintained more than 50 micrograms/ml even in cases of severe cholangitis with obstructive jaundice. These results indicate that MZPC is an useful antibiotic for the treatment of biliary tract infection.
T
T
Maeba
T
T
Hashimoto
T
T
Takeda
Y
Y
Shiraishi
H
H
Oike
H
H
Wakabayashi
G
G
Omori
S
S
Indo
E
E
Kunikata
M
M
Hayashi
D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy; D001646:Bile / Q000032:analysis*; D001660:Biliary Tract Diseases / Q000188:drug therapy / Q000378:metabolism; D002761:Cholangitis / Q000188:drug therapy* / Q000378:metabolism; D002779:Cholestasis / Q000378:metabolism; D005260:Female; D006801:Humans; D008099:Liver / Q000378:metabolism*; D008107:Liver Diseases / Q000378:metabolism; D008297:Male; D008802:Mezlocillin / Q000378:metabolism / Q000627:therapeutic use*; D008875:Middle Aged
D008802:Mezlocillin